Hebei Changshan Biochemical Pharmaceutical Co., Ltd. 300255.SZ Stock
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Price Chart
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. 300255.SZ Financial and Trading Overview
Contents
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Price Chart
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. 300255.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Q&A For Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Stock
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd. stock price | 9.88 CNY |
| Previous Close | 5.13 CNY |
| Open | 5.15 CNY |
| Bid | 5.12 CNY x N/A |
| Ask | 5.13 CNY x N/A |
| Day's Range | 5.06 - 5.15 CNY |
| 52 Week Range | 4.9 - 6.44 CNY |
| Volume | 6.26M CNY |
| Avg. Volume | 6.49M CNY |
| Market Cap | 4.79B CNY |
| Beta (5Y Monthly) | 0.452397 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.47 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 2, 2022 |
| 1y Target Est | N/A |
300255.SZ Valuation Measures
| Enterprise Value | 6.64B CNY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.1144361 |
| Price/Book (mrq) | 1.5366147 |
| Enterprise Value/Revenue | 2.934 |
| Enterprise Value/EBITDA | 52.119 |
Trading Information
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.452397 |
| 52-Week Change | -15.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.44 CNY |
| 52 Week Low | 4.9 CNY |
| 50-Day Moving Average | 5.25 CNY |
| 200-Day Moving Average | 5.6 CNY |
300255.SZ Share Statistics
| Avg. Volume (3 month) | 6.49M CNY |
| Avg. Daily Volume (10-Days) | 8.93M CNY |
| Shares Outstanding | 934.97M |
| Float | 458.31M |
| Short Ratio | N/A |
| % Held by Insiders | 54.64% |
| % Held by Institutions | 0.26% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.005 |
| Trailing Annual Dividend Yield | 0.097% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 18:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -0.33% |
| Operating Margin (ttm) | 3.10% |
| Gross Margin | 41.03% |
| EBITDA Margin | 5.62% |
Management Effectiveness
| Return on Assets (ttm) | 0.76% |
| Return on Equity (ttm) | -0.58% |
Income Statement
| Revenue (ttm) | 2.26B CNY |
| Revenue Per Share (ttm) | 2.59 CNY |
| Quarterly Revenue Growth (yoy) | -12.59% |
| Gross Profit (ttm) | 1.02B CNY |
| EBITDA | 127.44M CNY |
| Net Income Avi to Common (ttm) | -7596458 CNY |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | -84.70% |
Balance Sheet
| Total Cash (mrq) | 584.79M CNY |
| Total Cash Per Share (mrq) | 0.64 CNY |
| Total Debt (mrq) | 2.52B CNY |
| Total Debt/Equity (mrq) | 82.52 CNY |
| Current Ratio (mrq) | 2.07 |
| Book Value Per Share (mrq) | 3.332 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 62.06M CNY |
| Levered Free Cash Flow (ttm) | -430813984 CNY |
Profile of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
| Country | China |
| State | N/A |
| City | Shijiazhuang |
| Address | Zhengding County High-tech Ind Dev Zone |
| ZIP | 050800 |
| Phone | 83 311 8919 0181 |
| Website | https://www.heparin.cn |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1424 |
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.
Q&A For Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Stock
What is a current 300255.SZ stock price?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. 300255.SZ stock price today per share is 9.88 CNY.
How to purchase Hebei Changshan Biochemical Pharmaceutical Co., Ltd. stock?
You can buy 300255.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hebei Changshan Biochemical Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is 300255.SZ.
Which industry does the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. company belong to?
The Hebei Changshan Biochemical Pharmaceutical Co., Ltd. industry is Biotechnology.
How many shares does Hebei Changshan Biochemical Pharmaceutical Co., Ltd. have in circulation?
The max supply of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. shares is 919.06M.
What is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. PE Ratio is now.
What was Hebei Changshan Biochemical Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. EPS is -0.47 CNY over the trailing 12 months.
Which sector does the Hebei Changshan Biochemical Pharmaceutical Co., Ltd. company belong to?
The Hebei Changshan Biochemical Pharmaceutical Co., Ltd. sector is Healthcare.